Neuroinflammation in Huntington’s Disease: New Insights with 11 C-PBR28 PET/MRI

Scikit-learn: Machine Learning in Python

Pedregosa, F., Varoquaux, G., Gramfort, A., Michel, V., Thirion, B., Grisel, O., Blondel, M., Müller, A., Nothman, J., Louppe, G., et al. (2012) · arXiv · doi:10.48550/arxiv.1201.0490 · Cited by 71,016 · see citing works

Whole Brain Segmentation

Fischl, B., Salat, D. H., Busa, E., Albert, M., Dieterich, M., Haselgrove, C., van der Kouwe, A., Killiany, R., Kennedy, D., Klaveness, S., et al. (2002) · Neuron · doi:10.1016/s0896-6273(02)00569-x · Cited by 8,610 · see citing works

A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes

MACDONALD, M. (1993) · Cell · doi:10.1016/0092-8674(93)90585-e · Cited by 8,366 · see citing works

Scaling regression inputs by dividing by two standard deviations

Gelman, A. (2007) · Statistics in Medicine · doi:10.1002/sim.3107 · Cited by 2,536 · see citing works

Machine learning for neuroimaging with scikit-learn

Abraham, A., Pedregosa, F., Eickenberg, M., Gervais, P., Mueller, A., Kossaifi, J., Gramfort, A., Thirion, B., & Varoquaux, G. P. (2014) · Frontiers in Neuroinformatics · doi:10.3389/fninf.2014.00014 · Cited by 2,397 · see citing works

Unified Huntington's disease rating scale: Reliability and consistency

Kremer, H. P. H. (1996) · Movement Disorders · doi:10.1002/mds.870110204 · Cited by 2,109 · see citing works

Thinning of the Cerebral Cortex in Aging

Salat, D. H. (2004) · Cerebral Cortex · doi:10.1093/cercor/bhh032 · Cited by 1,851 · see citing works

Automated manifold surgery: constructing geometrically accurate and topologically correct models of the human cerebral cortex

Fischl, B. R., Liu, A., & Dale, A. M. (2001) · IEEE Transactions on Medical Imaging · doi:10.1109/42.906426 · Cited by 1,755 · see citing works

Reliability of MRI-derived measurements of human cerebral cortical thickness: The effects of field strength, scanner upgrade and manufacturer

Han, X., Jovicich, J., Salat, D., van der Kouwe, A., Quinn, B., Czanner, S., Busa, E., Pacheco, J., Albert, M., Killiany, R., et al. (2006) · NeuroImage · doi:10.1016/j.neuroimage.2006.02.051 · Cited by 1,508 · see citing works

Translocator protein (18kDa): new nomenclature for the peripheral-type benzodiazepine receptor based on its structure and molecular function

Papadopoulos, V., Baraldi, M., Guilarte, T. R., Knudsen, T. B., Lacapère, J.-J., Lindemann, P., Norenberg, M. D., Nutt, D., Weizman, A., Zhang, M.-R., et al. (2006) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2006.06.005 · Cited by 1,389 · see citing works

Performance Measurements of the Siemens mMR Integrated Whole-Body PET/MR Scanner

Delso, G., Fürst, S., Jakoby, B., Ladebeck, R., Ganter, C., Nekolla, S. G., Schwaiger, M., & Ziegler, S. I. (2011) · Journal of Nuclear Medicine · doi:10.2967/jnumed.111.092726 · Cited by 870 · see citing works

An 18-kDa translocator protein (TSPO) polymorphism explains differences in binding affinity of the PET radioligand PBR28

Owen, D. R., Yeo, A. J., Gunn, R. N., Song, K., Wadsworth, G., Lewis, A., Rhodes, C., Pulford, D. J., Bennacef, I., Parker, C. A., et al. (2012) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2011.147 · Cited by 779 · see citing works

Does neuroinflammation fan the flame in neurodegenerative diseases?

Frank-Cannon, T. C., Alto, L. T., McAlpine, F. E., & Tansey, M. G. (2009) · Molecular Neurodegeneration · doi:10.1186/1750-1326-4-47 · Cited by 751 · see citing works

Eliminating microglia in Alzheimer’s mice prevents neuronal loss without modulating amyloid-β pathology

Spangenberg, E. E., Lee, R. J., Najafi, A. R., Rice, R. A., Elmore, M. R. P., Blurton-Jones, M., West, B. L., & Green, K. N. (2016) · Brain · doi:10.1093/brain/aww016 · Cited by 695 · see citing works

Cleavage of huntingtin by apopain, a proapoptotic cysteine protease, is modulated by the polyglutamine tract

Goldberg, Y. P., Nicholson, D. W., Rasper, D., Kalchman, M. A., Koide, H., Graham, R. K., Bromm, M., Kazemi‐Esfarjani, P., Thornberry, N. A., Vaillancourt, J. P., et al. (1996) · Nature Genetics · doi:10.1038/ng0896-442 · Cited by 584 · see citing works

Caspase Cleavage of Gene Products Associated with Triplet Expansion Disorders Generates Truncated Fragments Containing the Polyglutamine Tract

Wellington, C. L., Ellerby, L., Hackam, A. S., Margolis, R. L., Trifiro, M. A., Singaraja, R. R., McCutcheon, K. M., Salvesen, G. S., Propp, S. S., Bromm, M., et al. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.15.9158 · Cited by 562 · see citing works

Early and Progressive Accumulation of Reactive Microglia in the Huntington Disease Brain

Sapp, E., Kegel, K. B., D, N. A. M., Hashikawa, T., Uchiyama, Y., Tohyama, K., Bhide, P. G., Vonsattel, J., & DiFiglia, M. (2001) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/60.2.161 · Cited by 537 · see citing works

Evidence for brain glial activation in chronic pain patients

Loggia, M. L., Chonde, D. B., Akeju, O., Arabasz, G., Catana, C., Edwards, R. R., Hill, E., Hsu, S., Izquierdo-Garcia, D., Ji, R.-R., et al. (2015) · Brain · doi:10.1093/brain/awu377 · Cited by 503 · see citing works

Cerebral cortex and the clinical expression of Huntington's disease: complexity and heterogeneity

Rosas, H. D., Salat, D. H., Lee, S. Y., Zaleta, A. K., Pappu, V., Fischl, B. R., Greve, D. N., Hevelone, N. D., & Hersch, S. M. (2008) · Brain · doi:10.1093/brain/awn025 · Cited by 497 · see citing works

Microglial activation correlates with severity in Huntington disease: A clinical and PET study

Pavese, N., Gerhard, A., Tai, Y. F., Ho, A. K., Turkheimer, F., Barker, R. A., Brooks, D. J., & Piccini, P. (2006) · Neurology · doi:10.1212/01.wnl.0000222734.56412.17 · Cited by 462 · see citing works

Cerebral metabolism and atrophy in huntington's disease determined by 18FDG and computed tomographic scan

Kuhl, D. E., Phelps, M. E., Markham, C. H., Metter, E. J., Riege, W. H., & Winter, J. (1982) · Annals of Neurology · doi:10.1002/ana.410120504 · Cited by 458 · see citing works

Microglial activation in presymptomatic Huntington's disease gene carriers

Tai, Y. F., Pavese, N., Gerhard, A., Tabrizi, S. J., Barker, R. A., Brooks, D. J., & Piccini, P. (2007) · Brain · doi:10.1093/brain/awm044 · Cited by 440 · see citing works

A mean three-dimensional atlas of the human thalamus: Generation from multiple histological data

Krauth, A. G. ⁄. N., Blanc, R., Poveda, A., Jeanmonod, D., Morel, A., & Székely, G. J. (2009) · NeuroImage · doi:10.1016/j.neuroimage.2009.10.042 · Cited by 381 · see citing works

Striatal glucose metabolism and dopamine D2 receptor binding in asymptomatic gene carriers and patients with Huntington's disease

Antonini, A., Leenders, K. L., Spiegel, R., Meier, D., Vontobel, P., Weigell-Weber, M., Sánchez‐Pernaute, R., de Yébenez, J. G., Boesiger, P., Weindl, A., et al. (1996) · Brain · doi:10.1093/brain/119.6.2085 · Cited by 317 · see citing works

Motor thalamus integration of cortical, cerebellar and basal ganglia information: implications for normal and parkinsonian conditions

Bosch‐Bouju, C., Hyland, B. I., & Parr‐Brownlie, L. C. (2013) · Frontiers in Computational Neuroscience · doi:10.3389/fncom.2013.00163 · Cited by 301 · see citing works

PK (‘peripheral benzodiazepine’) – binding sites in the CNS indicate early and discrete brain lesions: microautoradiographic detection of [3H]PK 11195 binding to activated microglia

Banati, R. B., Myers, R., & Kreutzberg, G. W. (1997) · Journal of Neurocytology · doi:10.1023/a:1018567510105 · Cited by 296 · see citing works

Brain white-matter volume loss and glucose hypometabolism precede the clinical symptoms of Huntington's disease.

Ciarmiello, A., Cannella, M., Lastoria, S., Simonelli, M., Frati, L., Rubinsztein, D. C., & Squitieri, F. (2006) · PubMed · Cited by 292 · see citing works

Comparison of [11C]-(R)-PK 11195 and [11C]PBR28, two radioligands for translocator protein (18 kDa) in human and monkey: Implications for positron emission tomographic imaging of this inflammation biomarker

Kreisl, W. C., Fujita, M., Fujimura, Y., Kimura, N., Jenko, K. J., Kannan, P., Hong, J. S., Morse, C. L., Zoghbi, S. S., Gladding, R. L., et al. (2009) · NeuroImage · doi:10.1016/j.neuroimage.2009.11.056 · Cited by 275 · see citing works

A Genetic Polymorphism for Translocator Protein 18 Kda Affects both in Vitro and in Vivo Radioligand Binding in Human Brain to this Putative Biomarker of Neuroinflammation

Kreisl, W. C., Jenko, K. J., Hines, C. S., Lyoo, C. H., Corona, W., Morse, C. L., Zoghbi, S. S., Hyde, T. M., Kleinman, J. E., Pike, V. W., et al. (2012) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2012.131 · Cited by 251 · see citing works

Topography of cerebral atrophy in early Huntington's disease: a voxel based morphometric MRI study.

Kassubek, J., Juengling, F. D., Kioschies, T. A., Henkel, K., Karitzky, J., Kramer, B., Ecker, D., Andrich, J., Carsten Saft, C., Kraus, P., et al. (2004) · PubMed Central · Cited by 245 · see citing works

Increased in vivo glial activation in patients with amyotrophic lateral sclerosis: Assessed with [11C]-PBR28

Zürcher, N. R., Loggia, M. L., Lawson, R., Chonde, D. B., Izquierdo-Garcia, D., Yasek, J. E., Akeju, O., Catana, C., Rosen, B. R., Cudkowicz, M. E., et al. (2015) · NeuroImage: Clinical · doi:10.1016/j.nicl.2015.01.009 · Cited by 226 · see citing works

An SPM8-Based Approach for Attenuation Correction Combining Segmentation and Nonrigid Template Formation: Application to Simultaneous PET/MR Brain Imaging

Izquierdo‐Garcia, D., Hansen, A. E., Förster, S., Benoit, D., Schachoff, S., Fürst, S., Chen, K. T., Chonde, D. B., & Catana, C. (2014) · Journal of Nuclear Medicine · doi:10.2967/jnumed.113.136341 · Cited by 218 · see citing works

Radiotracer synthesis from [11C]-iodomethane: a remarkably simple captive solvent method

Wilson, A. A., García, A., Jin, L., & Houle, S. (2000) · Nuclear Medicine and Biology · doi:10.1016/s0969-8051(00)00132-3 · Cited by 203 · see citing works

PET imaging with [11C]PBR28 can localize and quantify upregulated peripheral benzodiazepine receptors associated with cerebral ischemia in rat

Imaizumi, M., Kim, H. J., Zoghbi, S. S., Briard, E., Hong, J. S., Musachio, J. L., Ruetzler, C. A., Chuang, D., Pike, V. W., Innis, R. B., et al. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2006.09.093 · Cited by 177 · see citing works

Hypothalamic involvement in Huntington's disease: an in vivo PET study

Politis, M., Pavese, N., Tai, Y., Tabrizi, S. J., Barker, R., & Piccini, P. P. (2008) · Brain · doi:10.1093/brain/awn244 · Cited by 175 · see citing works

Neuropathology of Huntington's chorea

Dom, R., Malfroid, M., & Baro, F. (1976) · Neurology · doi:10.1212/wnl.26.1.64 · Cited by 140 · see citing works

Imaging microglial activation in Huntington's disease

Tai, Y., Pavese, N., Gerhard, A., Tabrizi, S. J., Barker, R. A., Brooks, D. J., & Piccini, P. P. (2006) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2006.10.029 · Cited by 137 · see citing works

Early atrophy of pallidum and accumbens nucleus in Huntington’s disease

TRACK-HD Investigator Group, van den Bogaard, S. J. A., Dumas, E. M., Acharya, T. P., Johnson, H. J., Langbehn, D. R., Scahill, R. I., Tabrizi, S. J., van Buchem, M. A., van der Grond, J., et al. (2010) · Journal of Neurology · doi:10.1007/s00415-010-5768-0 · Cited by 135 · see citing works

Reliability of brain volume measurements: A test-retest dataset

Maclaren, J., Han, Z., Vos, S. B., Fischbein, N. J., & Bammer, R. (2014) · Scientific Data · doi:10.1038/sdata.2014.37 · Cited by 125 · see citing works

Onset and Progression of Pathologic Atrophy in Huntington Disease: A Longitudinal MR Imaging Study

Hobbs, N. Z., Barnes, J., Frost, C. D., Henley, S. M. D., Wild, E. J., Macdonald, K. E., Barker, R., Scahill, R. I., Fox, N. C., & Tabrizi, S. J. (2010) · American Journal of Neuroradiology · doi:10.3174/ajnr.a2018 · Cited by 113 · see citing works

Current status of PET imaging in Huntington’s disease

Pagano, G., Niccolini, F., & Politis, M. (2016) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-016-3324-6 · Cited by 99 · see citing works

Saccadic impairments in Huntington’s disease

Peltsch, A. J., Hoffman, A., Armstrong, I. T., Pari, G., & Munoz, D. P. (2008) · Experimental Brain Research · doi:10.1007/s00221-007-1248-x · Cited by 88 · see citing works

Toward Understanding the Molecular Pathology of Huntington's Disease

Wellington, C. L., Brinkman, R. R., OʼKusky, J. R., & Hayden, M. R. (1997) · Brain Pathology · doi:10.1111/j.1750-3639.1997.tb00897.x · Cited by 71 · see citing works

Influence of TSPO Genotype on 11C-PBR28 Standardized Uptake Values

Yoder, K. K., Nho, K. T., Risacher, S. L., Kim, S., Shen, L., & Saykin, A. J. (2013) · Journal of Nuclear Medicine · doi:10.2967/jnumed.112.118885 · Cited by 67 · see citing works

18F-FDG PET uptake in the pre-Huntington disease caudate affects the time-to-onset independently of CAG expansion size

Ciarmiello, A., Giovacchini, G., Orobello, S., Bruselli, L., Elifani, F., & Squitieri, F. (2012) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-012-2114-z · Cited by 63 · see citing works

Automated quantification of caudate atrophy by local registration of serial MRI: Evaluation and application in Huntington's disease

Hobbs, N. Z., Henley, S. M. D., Wild, E. J., Leung, K. K., Frost, C. D., Barker, R. A., Scahill, R. I., Barnes, J., Tabrizi, S. J., & Fox, N. C. (2009) · NeuroImage · doi:10.1016/j.neuroimage.2009.06.003 · Cited by 54 · see citing works

Neuroprotection for Huntington’s Disease: Ready, Set, Slow

Hersch, S. M., & Rosas, H. D. (2008) · Neurotherapeutics · doi:10.1016/j.nurt.2008.01.003 · Cited by 44 · see citing works

Neuroprotective therapy for Huntington’s disease: new prospects and challenges

Hersch, S. M., & Rosas, H. D. (2001) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.1.1.111 · Cited by 12 · see citing works

Untitled work

(2000) · doi:10.1002/1531-8257(200005)15:3

Brain glial activation in fibromyalgia – A multi-site positron emission tomography investigation

Albrecht, D. S., Forsberg, A., Sandström, A., Bergan, C., Kadetoff, D., Protsenko, E., Lampa, J., Lee, Y. C., Höglund, C. O., Catana, C., et al. (2019) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2018.09.018 · Cited by 310 · see citing works

PET Imaging of Neuroinflammation in Neurological Disorders

Kreisl, W., Kim, M.-J., Coughlin, J. M., Henter, I., Owen, D. R., & Innis, R. (2020) · Lancet Neurology · doi:10.1016/s1474-4422(20)30346-x · Cited by 180 · see citing works

Recent developments on PET radiotracers for TSPO and their applications in neuroimaging

Zhang, L., Hu, K., Shao, T., Hou, L., Zhang, S., Ye, W., Josephson, L., Meyer, J. H., Zhang, M., Vasdev, N., et al. (2020) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2020.08.006 · Cited by 187 · see citing works

Cyclic GMP-AMP synthase promotes the inflammatory and autophagy responses in Huntington disease

Sharma, M., Rajendrarao, S., Shahani, N., Ramírez-Jarquín, U. N., & Subramaniam, S. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2002144117 · Cited by 155 · see citing works

Hyperactivation of P2X7 receptors as a culprit of COVID-19 neuropathology

Ribeiro, D. E., Oliveira-Giacomelli, Á., Glaser, T., Arnaud-Sampaio, V. F., Andrejew, R., Dieckmann, L., Baranova, J., Lameu, C., Ratajczak, M. Z., & Ulrich, H. (2021) · Molecular Psychiatry · doi:10.1038/s41380-020-00965-3 · Cited by 145 · see citing works

The Neuroimmunology of Chronic Pain: From Rodents to Humans

Grace, P. M., Tawfik, V. L., Svensson, C. I., Burton, M. D., Loggia, M. L., & Hutchinson, M. R. (2020) · Journal of Neuroscience · doi:10.1523/jneurosci.1650-20.2020 · Cited by 133 · see citing works

The role of Nrf2 in neural stem/progenitors cells: From maintaining stemness and self-renewal to promoting differentiation capability and facilitating therapeutic application in neurodegenerative disease

Kahroba, H., Ramezani, B., Maadi, H., Sadeghi, M. R., Jaberie, H., & Ramezani, F. (2020) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101211 · Cited by 129 · see citing works

In-vivo imaging of neuroinflammation in veterans with Gulf War illness

Alshelh, Z., Albrecht, D., Bergan, C., Akeju, O., Clauw, D. J., Conboy, L. A., Edwards, R. R., Kim, M., Lee, Y., Protsenko, E., et al. (2020) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2020.01.020 · Cited by 120 · see citing works

Healthy lifestyles and wellbeing reduce neuroinflammation and prevent neurodegenerative and psychiatric disorders

Kip, E., & Parr‐Brownlie, L. C. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1092537 · Cited by 96 · see citing works

Neuroimmune signatures in chronic low back pain subtypes

Alshelh, Z., Brusaferri, L., Saha, A., Morrissey, E. J., Knight, P. C., Kim, M., Zhang, Y., Hooker, J. M., Albrecht, D., Torrado-Carvajal, Á., et al. (2021) · Brain · doi:10.1093/brain/awab336 · Cited by 86 · see citing works

The neuroinflammatory component of negative affect in patients with chronic pain

Albrecht, D., Kim, M., Akeju, O., Torrado-Carvajal, Á., Edwards, R. R., Zhang, Y., Bergan, C., Protsenko, E., Kucyi, A., Wasan, A. D., et al. (2019) · Molecular Psychiatry · doi:10.1038/s41380-019-0433-1 · Cited by 77 · see citing works

Imaging Neuroinflammation in Neurodegenerative Disorders

Masdeu, J. C., Pascual, B., & Fujita, M. (2022) · Journal of Nuclear Medicine · doi:10.2967/jnumed.121.263200 · Cited by 76 · see citing works

Role of Hypoxia Inducible Factor-1α in Alzheimer’s Disease

Wang, Y., Huang, Z., Yuan, M., Feng, J., Cai, R.-L., Zou, Q., Pu, Y., Wang, S., Chen, F., Yi, W., et al. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-201448 · Cited by 71 · see citing works

Diagnostic and Therapeutic Potential of TSPO Studies Regarding Neurodegenerative Diseases, Psychiatric Disorders, Alcohol Use Disorders, Traumatic Brain Injury, and Stroke: An Update

Dimitrova‐Shumkovska, J., Krstanoski, L., & Veenman, L. (2020) · Cells · doi:10.3390/cells9040870 · Cited by 70 · see citing works

Role of ferroptosis pathways in neuroinflammation and neurological disorders: From pathogenesis to treatment

Mohan, S., Alhazmi, H. A., Hassani, R., Khuwaja, G., Maheshkumar, V. P., Aldahish, A. A., & Chidambaram, K. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e24786 · Cited by 67 · see citing works

[11C]PBR28 MR–PET imaging reveals lower regional brain expression of translocator protein (TSPO) in young adult males with autism spectrum disorder

Zürcher, N. R., Loggia, M. L., Mullett, J. E., Tseng, C.-E. J., Bhanot, A., Richey, L., Hightower, B. G., Wu, C. J., Parmar, A. J., Butterfield, R. I., et al. (2020) · Molecular Psychiatry · doi:10.1038/s41380-020-0682-z · Cited by 70 · see citing works

Crosstalk Between the NLRP3 Inflammasome/ASC Speck and Amyloid Protein Aggregates Drives Disease Progression in Alzheimer’s and Parkinson’s Disease

Hulse, J. P., & Bhaskar, K. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.805169 · Cited by 60 · see citing works

Neuroinflammation in the Cerebellum and Brainstem in Friedreich Ataxia: An [ 18F ]‐ FEMPA PET Study

Khan, W., Corben, L. A., Bilal, H., Vivash, L. E., Delatycki, M. B., Egan, G. F., & Harding, I. H. (2021) · Movement Disorders · doi:10.1002/mds.28825 · Cited by 54 · see citing works

Microglia Activation in Basal Ganglia Is a Late Event in Huntington Disease Pathophysiology

Rocha, N. P., Charron, O., Latham, L. B., Colpo, G. D., Zanotti-Fregonara, P., Yu, M., Freeman, L., Furr Stimming, E., & Teixeira, A. L. (2021) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000000984 · Cited by 52 · see citing works

Exploring Huntington’s Disease Diagnosis via Artificial Intelligence Models: A Comprehensive Review

Sowmiyalakshmi, G., Chithambaram, T., Krishnan, N. R., Vincent, P. M. D. R., Kaliappan, J., & Srinivasan, K. (2023) · Diagnostics · doi:10.3390/diagnostics13233592 · Cited by 54 · see citing works

Have (R)-[11C]PK11195 challengers fulfilled the promise? A scoping review of clinical TSPO PET studies

Chauveau, F., Becker, G., & Boutin, H. (2021) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-021-05425-w · Cited by 45 · see citing works

The epigenetic modification of DNA methylation in neurological diseases

Li, L., Chen, R., Zhang, H., Li, J., Huang, H., Weng, J., Tan, H., Guo, T., Wang, M., & Xie, J. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1401962 · Cited by 54 · see citing works

Thalamic neuroinflammation as a reproducible and discriminating signature for chronic low back pain

Torrado-Carvajal, Á., Toschi, N., Albrecht, D., Chang, K., Akeju, O., Kim, M., Edwards, R. R., Zhang, Y., Hooker, J. M., Duggento, A., et al. (2020) · Pain · doi:10.1097/j.pain.0000000000002108 · Cited by 46 · see citing works

New insight on microglia activation in neurodegenerative diseases and therapeutics

Xu, Y., Gao, W., Sun, Y., & Wu, M. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1308345 · Cited by 49 · see citing works

Novel PET Imaging of Inflammatory Targets and Cells for the Diagnosis and Monitoring of Giant Cell Arteritis and Polymyalgia Rheumatica

van der Geest, K. S. M., Sandovici, M., Nienhuis, P. H., Slart, R. H. J. A., Heeringa, P., Brouwer, E., & Jiemy, W. F. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.902155 · Cited by 39 · see citing works

Regional patterns of human cortex development correlate with underlying neurobiology

Lotter, L. D., Saberi, A., Hansen, J. Y., Mišić, B., Paquola, C., Barker, G. J., Bokde, A. L. W., Desrivières, S., Flor, H., Grigis, A., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-52366-7 · Cited by 47 · see citing works

An Overview of the Pathophysiological Mechanisms of 3-Nitropropionic Acid (3-NPA) as a Neurotoxin in a Huntington's Disease Model and Its Relevance to Drug Discovery and Development

Upadhayay, S., Yedke, N. G., Rahi, V., Singh, S., Kumar, S., Arora, A., Chandolia, P., Kaur, P., Kumar, M., Koshal, P., et al. (2023) · Neurochemical Research · doi:10.1007/s11064-023-03868-1 · Cited by 36 · see citing works

Essential Principles and Recent Progress in the Development of TSPO PET Ligands for Neuroinflammation Imaging

Viviano, M., Barresi, E., Siméon, F. G., Costa, B., Taliani, S., Settimo, F. D., Pike, V. W., & Castellano, S. (2022) · Current Medicinal Chemistry · doi:10.2174/0929867329666220329204054 · Cited by 34 · see citing works

Novel PET Biomarkers to Disentangle Molecular Pathways across Age-Related Neurodegenerative Diseases

Wilson, H., Politis, M., Rabiner, E. A., & Middleton, L. T. (2020) · Cells · doi:10.3390/cells9122581 · Cited by 34 · see citing works

Neuroprotective effects of roflumilast against quinolinic acid-induced rat model of Huntington’s disease through inhibition of NF-κB mediated neuroinflammatory markers and activation of cAMP/CREB/BDNF signaling pathway

Saroj, P., Bansal, Y., Singh, R., Akhtar, A., Sodhi, R., Bishnoi, M., Sah, S. P., & Kuhad, A. (2021) · InflammoPharmacology · doi:10.1007/s10787-020-00787-3 · Cited by 29 · see citing works

Neuroinflammatory Proteins in Huntington’s Disease: Insights into Mechanisms, Diagnosis, and Therapeutic Implications

Li, X., Tong, H., Xu, S., Zhou, G., Yang, T., Yin, S., Yang, S., Li, X., & Li, S. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252111787 · Cited by 31 · see citing works

Inflammation and Huntington’s disease – a neglected therapeutic target?

Field, S., Curle, A. J., & Barker, R. A. (2024) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2024.2348738 · Cited by 28 · see citing works

Visualization of Acute Inflammation through a Macrophage-Camouflaged Afterglow Nanocomplex

Wang, X., Yuan, W., Xu, M., Su, X., & Li, F. (2021) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.1c19388 · Cited by 27 · see citing works

Translating cell therapies for neurodegenerative diseases: Huntington’s disease as a model disorder

Rosser, A., Busse, M. E., Gray, W., Badin, R. A., Perrier, A. L., Wheelock, V., Cozzi, E., Perpiñá, U., Salado-Manzano, C., Mills, L. J., et al. (2022) · Brain · doi:10.1093/brain/awac086 · Cited by 26 · see citing works

Human Glial Cells as Innovative Targets for the Therapy of Central Nervous System Pathologies

Magni, G., Riboldi, B., & Ceruti, S. (2024) · Cells · doi:10.3390/cells13070606 · Cited by 25 · see citing works

Imaging brain inflammation and blood brain barrier permeability in neurological and psychiatric diseases: a review

Kovbasyuk, Z., Tefera, E., Li, C., Baete, S. H., & Steriade, C. (2025) · Journal of Neuroinflammation · doi:10.1186/s12974-025-03598-x · Cited by 23 · see citing works

In Situ Detection of Neuroinflammation Using Multicellular 3D Neurovascular‐Unit‐on‐a‐Chip

Choi, J., Choi, H. K., & Lee, K. (2023) · Advanced Functional Materials · doi:10.1002/adfm.202304382 · Cited by 21 · see citing works

Resveratrol prevents cognitive impairment and hippocampal inflammatory response induced by lipopolysaccharide in a mouse model of chronic neuroinflammation

Zeini, S., Davoodian, N., Kazemi, H., Brojeni, M. S., Ghani, E., Firouzjaei, M. A., & Atashabparvar, A. (2024) · Physiology & Behavior · doi:10.1016/j.physbeh.2024.114508 · Cited by 19 · see citing works

The innovative design of a delivery and real-time tracer system for anti-encephalitis drugs that can penetrate the blood-brain barrier

Wang, X., Song, B., Wang, Z., Qin, L., & Liang, W. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.09.043 · Cited by 18 · see citing works

Regional patterns of human cortex development correlate with underlying neurobiologyPreprint

Lotter, L. D., Saberi, A., Hansen, J. Y., Mišić, B., Paquola, C., Barker, G. J., Bokde, A. L. W., Desrivières, S., Flor, H., Grigis, A., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.05.05.539537 · Cited by 17 · see citing works

Positron Emission Tomography of Neuroimmune Responses in Humans: Insights and Intricacies

Raval, N. R., Wetherill, R. R., Wiers, C. E., Dubroff, J. G., & Hillmer, A. T. (2022) · Seminars in Nuclear Medicine · doi:10.1053/j.semnuclmed.2022.08.008 · Cited by 15 · see citing works

In silico Strategy: A Promising Implement in the Development of Multitarget Drugs against Neurodegenerative Diseases

Banjare, P., Matore, B. W., Murmu, A., Kumar, V., Singh, J., & Roy, P. P. (2023) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026623666230811113231 · Cited by 15 · see citing works

Multimodal Investigation of Neuroinflammation in Aviremic Patients With HIV on Antiretroviral Therapy and HIV Elite Controllers

Sari, H., Galbusera, R., Bonnier, G., Lin, Y., Alshelh, Z., Torrado-Carvajal, Á., Mukerji, S. S., Ratai, E., Gandhi, R. T., Chu, J. T., et al. (2022) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000001144 · Cited by 15 · see citing works

Neuroinflammation in Huntington's disease: Causes, consequences, and treatment strategies

Blusch, A., & Björkqvist, M. (2025) · Journal of Huntington s Disease · doi:10.1177/18796397251338207 · Cited by 13 · see citing works

In vivo translocator protein in females with autism spectrum disorder: a pilot study

Tseng, C.-E. J., Canales, C., Marcus, R. E. G., Parmar, A. J., Hightower, B. G., Mullett, J. E., Makary, M. M., Tassone, A. U., Saro, H. K., Hickey, P. C., et al. (2024) · Neuropsychopharmacology · doi:10.1038/s41386-024-01859-6 · Cited by 13 · see citing works

Focused Ultrasound-Mediated Disruption of the Blood–Brain Barrier for AAV9 Delivery in a Mouse Model of Huntington’s Disease

Owusu-Yaw, B. S., Zhang, Y., Garrett, L., Yao, A., Shing, K., Batista, A. R., Sena‐Esteves, M., Upadhyay, J., Kegel-Gleason, K. B., & Todd, N. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16060710 · Cited by 13 · see citing works

Phospholipid Profiles Are Selectively Altered in the Putamen and White Frontal Cortex of Huntington’s Disease

Phillips, G. R., Hancock, S. E., Jenner, A. M., McLean, C., Newell, K. A., & Mitchell, T. W. (2022) · Nutrients · doi:10.3390/nu14102086 · Cited by 11 · see citing works

Advances in Cellular and Cell-Free Therapy Medicinal Products for Huntington Disease Treatment

Kerkis, I., Araldi, R. P., Wenceslau, C. V., & Mendes, T. B. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.102539 · Cited by 11 · see citing works

[ 18 F]LW223 has low non-displaceable binding in murine brain, enabling high sensitivity TSPO PET imaging

Knyzeliene, A., MacAskill, M. G., Alcaide-Corral, C. J., Morgan, T. E., Henry, M. C., Lucatelli, C., Pimlott, S. L., Sutherland, A. J., & Tavares, A. (2023) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x231205661 · Cited by 9 · see citing works

A Novel Huntington's Disease Mouse Model to Assess the Role of Neuroinflammation on Disease Progression and to Develop Human Cell Therapies

Dahlenburg, H., Cameron, D. L., Yang, S., Bachman, A. M., Pollock, K., Cary, W., Pham, M. T., Hendrix, K. J., White, J. L., Nelson, H., et al. (2021) · Stem Cells Translational Medicine · doi:10.1002/sctm.20-0431 · Cited by 8 · see citing works

PET Imaging of Neuroinflammation

Chaney, A. M., Deal, E. M., Jackson, I. M., & James, M. L. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-816386-3.00047-8 · Cited by 9 · see citing works

Design, synthesis, and biological evaluation of new thalidomide–donepezil hybrids as neuroprotective agents targeting cholinesterases and neuroinflammation

Ortiz, C. J. C., Silva, M. D. F., Pruccoli, L., Nadur, N. F., de Azevedo, L. L., Kümmerle, A. E., Guedes, I. A., Dardenne, L. E., Coelho, L. F. L., Guimarães, M. J. R., et al. (2022) · RSC Medicinal Chemistry · doi:10.1039/d1md00374g · Cited by 9 · see citing works

Preclinical translational platform of neuroinflammatory disease biology relevant to neurodegenerative disease

Larson, K. C., Martens, L. H., Marconi, M., Dejesus, C., Bruhn, S., Miller, T. A., Tate, B. A., & Levenson, J. M. (2024) · Journal of Neuroinflammation · doi:10.1186/s12974-024-03029-3 · Cited by 9 · see citing works

Toll-Like Receptor 4 Plays a Significant Role in the Biochemical and Neurological Alterations Observed in Two Distinct Mice Models of Huntington’s Disease

Martínez‐Gopar, P. E., Pérez‐Rodríguez, M. J., Angeles-López, Q. D., Tristán-López, L. A., González‐Espinosa, C., & Pérez‐Severiano, F. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03234-w · Cited by 7 · see citing works

Exploring Translocator Protein (TSPO) Medicinal Chemistry: An Approach for Targeting Radionuclides and Boron Atoms to Mitochondria

Giordani, A., Menziani, M. C., Moresco, R. M., Matarrese, M., Paolino, M., Saletti, M., Giuliani, G., Anzini, M., & Cappelli, A. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c00379 · Cited by 6 · see citing works

Examination of Anti-Inflammatory Effects After Propionate Supplementation in the R6/2 Mouse Model of Huntington’s Disease

König, J., Blusch, A., Fatoba, O., Gold, R., Carsten Saft, C., & Ellrichmann, G. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26073318 · Cited by 5 · see citing works

A scoping review on potential of novel developments in fever of unknown origin and inflammation of unknown origin: long-axial-field-of-view positron emission tomography/computed tomography and novel radiotracers

Franco, M. D., Giorgio, A. D., Farolfi, A., Michelle, A. M. O. N., Mingels, C., Nardo, L., & Triumbari, E. K. A. (2025) · The Quarterly Journal of Nuclear Medicine and Molecular Imaging · doi:10.23736/s1824-4785.25.03656-8 · Cited by 4 · see citing works

[ 11 C]PBR28 radiotracer kinetics are not driven by alterations in cerebral blood flow

Sander, C. Y. M., Bovo, S., Torrado-Carvajal, Á., Albrecht, D., Deng, H., Napadow, V., Price, J. C., Hooker, J. M., & Loggia, M. L. (2021) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x211023387 · Cited by 4 · see citing works

Investigating Neuron Degeneration in Huntington’s Disease Using RNA-Seq Based Transcriptome Study

Sneha, N. P., Dharshini, S. A. P., Taguchi, Y., & Gromiha, M. M. (2023) · Genes · doi:10.3390/genes14091801 · Cited by 4 · see citing works

Positron Emission Tomography (PET) Imaging Biomarkers in Huntington’s Disease

Everix, L., Staelens, S. G., & Bertoglio, D. (2023) · Contemporary clinical neuroscience · doi:10.1007/978-3-031-32815-2_6 · Cited by 4 · see citing works

Treating Depression and Suicidality in Huntington's Disease

Greenberg, M., Paddu, N., Bhivandkar, S., & Ahmed, S. (2020) · Psychiatric Annals · doi:10.3928/00485713-20200107-01 · Cited by 4 · see citing works

PET Imaging of Translocator Protein Expression in Neurological Disorders

Brooks, D. J. (2020) · Springer eBooks · doi:10.1007/978-3-030-53176-8_30 · Cited by 4 · see citing works

Choroid plexus alterations in autism spectrum disorder: A PET-MRI study

Lila, Y., Tseng, C.-E. J., Johnston, E. G., Canales, C., McDougle, C. J., Hooker, J. M., & Zürcher, N. R. (2025) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2025.106110 · Cited by 3 · see citing works

Linking brain entropy to molecular and cellular architecture in psychosis

Li, Q., Liu, J., & Calhoun, V. D. (2025) · NeuroImage · doi:10.1016/j.neuroimage.2025.121537 · Cited by 3 · see citing works

Imaging Biomarkers in Huntington’s Disease

de Natale, E. R., Wilson, H., & Politis, M. (2021) · Neuromethods · doi:10.1007/978-1-0716-1712-0_19 · Cited by 2 · see citing works

Neuroinflammation in Huntington’s Disease

Lee, J. D., Lo, M. W., Fung, J. N., & Woodruff, T. M. (2021) · Neuromethods · doi:10.1007/978-1-0716-1712-0_9 · Cited by 2 · see citing works

cGAS, a DNA Sensor, Promotes Inflammatory Responses in Huntington DiseasePreprint

Sharma, M., Rajendrarao, S., Shahani, N., Ramírez-Jarquín, U. N., & Subramaniam, S. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.01.08.898718 · Cited by 2 · see citing works

Oligodendroglial Mutant Huntingtin Contributes to Neuroinflammation in Huntington’s Disease Mice

Li, X. J., Zhou, G., Xu, S., Yang, T., Yin, S., Yang, S., Wu, Y., Zhou, X., Yang, S., Tong, H., et al. (2026) · Neuroscience Bulletin · doi:10.1007/s12264-025-01565-3 · Cited by 1 · see citing works

Subcortical microglial inflammation is uniquely linked to subpial cortical demyelination in multiple sclerosis

Thevakumaran, R., Blinder, S., Couch, M. J., Kostikov, A., Arnaoutelis, R., Narayanan, S., Rosa-Neto, P., Arnold, D. L., & Rudko, D. (2026) · NeuroImage: Clinical · doi:10.1016/j.nicl.2026.103962 · Cited by 1 · see citing works

Design, Synthesis, and Evaluation of [ 68 Ga/ 177 Lu]-Labeled TSPO-Targeting Radioligands for PET/CT Diagnosis and Radionuclide Therapy of Brain Tumor

Wang, X., Zhang, S., Li, Y., Liu, C., Wu, J., Wu, Y., Hu, Q., Liu, W. T., Lu, Q., Hu, X., et al. (2026) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5c03527 · Cited by 1 · see citing works

Neuroimaging Biomarkers for Huntington’s Disease

van de Zande, N. A., Ghariq, E., de Bresser, J., & de Bot, S. T. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.102528 · Cited by 1 · see citing works

Microglial Activation and Neuroinflammation

Kreisl, W. C. (2021) · Springer eBooks · doi:10.1007/978-3-030-82367-2_17

Molecular imaging in Huntington's disease

de Natale, E. R., Wilson, H., Niccolini, F., & Politis, M. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-821651-4.00014-2

Multi-functional Ligands and Molecular Hybridization: Conceptual Aspects and Application in the Innovative Design of Drug Candidate Prototypes for Neurodegenerative Diseases

Silva, M. D. F., Viegas, F. P. D., Gontijo, V. S., Ortiz, C. J. C., Franco, G. D. R. R., Ernesto, J. T., Damásio, C. M., Fonseca, G. P. D. S., Silva, I. M. F., Massuda, L. E., et al. (2023) · Frontiers in clinical drug research. CNS and neurological disorders · doi:10.2174/9789815123319123110003

Neuroinflammation Imaging in Neurodegenerative Diseases

Hammoud, D. A., & Herscovitch, P. (2023) · Springer eBooks · doi:10.1007/978-3-031-35098-6_9

An Overview of Huntington’s Disease using Machine Learning

Felix, M. J., & Sharmila, K. (2024) · International Journal of Advanced Research in Science Communication and Technology · doi:10.48175/ijarsct-19058

Additional file 1 of Preclinical translational platform of neuroinflammatory disease biology relevant to neurodegenerative disease

Larson, K. C., Martens, L. H., Marconi, M., Dejesus, C., Bruhn, S., Miller, T. A., Tate, B. A., & Levenson, J. M. (2024) · Figshare · doi:10.6084/m9.figshare.26675186

Additional file 2 of Preclinical translational platform of neuroinflammatory disease biology relevant to neurodegenerative disease

Larson, K. C., Martens, L. H., Marconi, M., Dejesus, C., Bruhn, S., Miller, T. A., Tate, B. A., & Levenson, J. M. (2024) · Figshare · doi:10.6084/m9.figshare.26675189

Additional file 3 of Preclinical translational platform of neuroinflammatory disease biology relevant to neurodegenerative disease

Larson, K. C., Martens, L. H., Marconi, M., Dejesus, C., Bruhn, S., Miller, T. A., Tate, B. A., & Levenson, J. M. (2024) · Figshare · doi:10.6084/m9.figshare.26675192

Additional file 4 of Preclinical translational platform of neuroinflammatory disease biology relevant to neurodegenerative disease

Larson, K. C., Martens, L. H., Marconi, M., Dejesus, C., Bruhn, S., Miller, T. A., Tate, B. A., & Levenson, J. M. (2024) · Figshare · doi:10.6084/m9.figshare.26675195

Imaging in Movement Disorders: A Clinician's Perspective on Novel Applications

Smith, K. M., & Saranathan, M. (2025) · Seminars in Neurology · doi:10.1055/a-2769-6508

Spatial organization of AQP4 water channel expression in the human brain

Taheri, T., Farahani, A., Liu, Z.-Q., Ceballos, E. G., Harroud, A., Dagher, A., & Mišić, B. (2026) · Science Advances · doi:10.1126/sciadv.aeg8117

The central neurometabolic fingerprint of persistent spinal pain syndrome type 2: A prospective [18F]FDG PET/CT neuroimaging study

Burmeister, L. S., van Grinsven, M., van Roosendaal, B.-K. W. P., Witkam, R. L., Arnts, I., Janssen, S., Wegener, J. T., Vissers, K. C. P., Arens, A. I. J., Gotthard, M., et al. (2026) · Neurobiology of Pain · doi:10.1016/j.ynpai.2026.100235

BindingDB Entry 50015900: Design, synthesis, and biological evaluation of new thalidomide-donepezil hybrids as neuroprotective agents targeting cholinesterases and neuroinflammation.

BindingDB (2023) · UC San Diego · doi:10.7270/q29k4g7q

BindingDB Entry 50018267: Exploring Translocator Protein (TSPO) Medicinal Chemistry: An Approach for Targeting Radionuclides and Boron Atoms to Mitochondria.

BindingDB (2024) · UC San Diego · doi:10.7270/q23x8bv7

TSPO–PET imaging using [18F]PBR06 is a potential translatable biomarker for treatment response in Huntington’s disease: preclinical evidence with the p75NTR ligand LM11A-31

Simmons, D. A., James, M. L., Belichenko, N. P., Semaan, S., Condon, C., Kuan, J., Shuhendler, A. J., Miao, Z., Chin, F. T., & Longo, F. M. (2018) · Human Molecular Genetics · doi:10.1093/hmg/ddy202 · Cited by 44 · see citing works

Distinct neuroinflammatory profile in post-mortem human Huntington's disease

Silvestroni, A., Faull, R. L. M., Strand, A. D., & Möller, T. (2009) · Neuroreport · doi:10.1097/wnr.0b013e32832e34ee · Cited by 204 · see citing works

PET Imaging in Huntington’s Disease

Roussakis, A., & Piccini, P. P. (2015) · Journal of Huntington s Disease · doi:10.3233/jhd-150171 · Cited by 22 · see citing works

11C-PBR28 PET to assess the level of brain microglia activation in Huntington's Disease patients

Gennaro, M. (2018) · Electronic Theses and Dissertations Repository (University of Pisa)

Selected CSF biomarkers indicate no evidence of early neuroinflammation in Huntington disease

Vinther‐Jensen, T., Börnsen, L. S., Budtz–Jørgensen, E., Ammitzbøll, C., Larsen, I. U., Hjermind, L. E., Sellebjerg, F. T., & Nielsen, J. E. (2016) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000000287 · Cited by 62 · see citing works